| Net loss | -2.55M |
| Stock-based compensation expense | 1.13M |
| Depreciation expense | |
| Change in fair value of warrant liability | |
| Accounts receivable | |
| Grant receivable | |
| Prepaid expenses, deposits and other | |
| Accounts payable | -387K |
| Accrued liabilities | -51K |
| Deferred revenue | -442K |
| Net cash used in operating activities | -2.44M |
| Purchase of property and equipment | -17K |
| Net cash used in investing activities | -17K |
| Purchase of treasury stock | |
| Proceeds from exercise of options and warrants | |
| Net cash provided by (used in) financing activities | 4.33M |
| Exchange rate effect on cash and cash equivalents | |
| Decrease in cash and cash equivalents | 1.88M |
| Cash and cash equivalents, beginning of period | 2.59M |
| Cash and cash equivalents, end of period | 4.5M |